Patents by Inventor Hervé SEITZ

Hervé SEITZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF COVID-19 WITH REVERSE MICELLE SYSTEM COMPRISING UNMODIFIED OLIGONUCLEOTIDES
    Publication number: 20230144739
    Abstract: The present invention relates to specific reverse micelle system of the invention which allows the administration and intracellular delivery of unmodified oligonucleotide, such as siRNA, targeting one or more genes of the SARS-CoV-2 virus. The reverse micelle system of the invention is thus particularly useful for the treatment of the viral pathology linked to the SARS-CoV-2 virus.
    Type: Application
    Filed: March 15, 2021
    Publication date: May 11, 2023
    Inventors: Jean-Claude MAUREL, Abdelkader MOURI, Hervé SEITZ, Sophie MOCKLY
  • TREATMENT OF COVID-19 WITH REVERSE MICELLE SYSTEM COMPRISING UNMODIFIED OLIGONUCLEOTIDES
    Publication number: 20230129386
    Abstract: The present disclosure relates to specific reverse micelle system that allows for the administration and intracellular delivery of unmodified oligonucleotide, such as siRNA, targeting one or more genes of the SARS-CoV-2 virus. The reverse micelle systems described herein are particularly useful for the treatment of COVID-19.
    Type: Application
    Filed: September 15, 2022
    Publication date: April 27, 2023
    Inventors: Hervé SEITZ, Abdelkader MOURI, Jean-Claude MAUREL